eIF2α (D-3) Antibody from Santa Cruz Biotechnology, Inc.

Yes, the eIF2α (D-3) Antibody has been utilized in studies examining the integrated stress response, particularly in the context of stress granule dynamics and the phosphorylation of eIF2α, which is crucial for cellular stress responses (Pathak et al., 2019; Wang et al., 2019).

The eIF2α (D-3) Antibody has been shown to react with proteins from multiple species, including humans, mice, and rats, making it suitable for comparative studies across these organisms (Santa Cruz Biotechnology, Inc.).

This antibody has been cited in studies investigating the role of eIF2α in cancer, such as its involvement in the unfolded protein response and stress granule formation, which are critical for understanding cancer cell survival and resistance to therapies (Kim et al., 2021; Melixetian et al., 2021).

The eIF2α (D-3) Antibody is versatile and has been successfully used in various applications, including Western blotting, immunofluorescence, and immunohistochemistry, allowing for detailed analysis of eIF2α expression and phosphorylation in different experimental setups (Hernández-Suárez et al., 2023; Mello et al., 2021).